J Neurol Neurosurg Psychiatry 76:1469-1471 doi:10.1136/jnnp.2005.071837
  • Herpes simplex virus encephalitis
  • Editorial commentary

Corticosteroids in herpes simplex virus encephalitis

  1. H Openshaw,
  2. E M Cantin
  1. Departments of Neurology and Virology, City of Hope National Medical Center and Beckman Research Institute, Duarte, CA, USA
  1. Correspondence to:
 Dr Harry Openshaw
 City of Hope National Medical Center, 1500 E. Duarte Road, Duarte, CA 91010, USA;

    The effectiveness of corticosteroids in herpes simplex virus encephalitis is not proven

    Despite receiving standard antiviral therapy, an appreciable number of patients with herpes simplex virus encephalitis (HSVE) experience poor acute outcome or delayed neurological progression. It is uncertain whether all poor outcomes are due to viral cytopathology or whether an immune mediated pathogenesis also occurs. In support of an immunopathological cause, Kamei et al (see pages XX–XX of this issue) report that corticosteroid administration was a significant predictor of favourable outcome at 3 months after HSVE infection.

    Immune cells persist and elaborate cytokines in the nervous system long after the virus has entered latency.1 It is …

    Visit the full archive of podcasts for JNNP here >>

    Free sample
    This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of JNNP.
    View free sample issue >>

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

    Navigate This Article